News

AVEO Oncology announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has recommended FOTIVDA…
Read More...

DURECT Corporation announced that patient enrollment has been completed in PERSIST, the pivotal Phase 3 clinical trial of POSIMIR (SABER-Bupivacaine), an investigational locally acting,…
Read More...

Ewopharma, a pharmaceutical marketing company and Eisai Co., Ltd. (TYO: 4523), a leading global research and development-based pharmaceutical company are pleased to announce that as of…
Read More...

Seqirus announced the next major advancement in the use of cell-based technology at its state-of-the art manufacturing facility in Holly Springs, North Carolina. In an industry…
Read More...

A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court…
Read More...

Smithers Avanza, a contract research organization (CRO) supporting the pharmaceutical industry, announced that it has added three additional instruments to its bioanalytical laboratory,…
Read More...

Almac Discovery and Debiopharm International announced a collaboration to pursue the development of Almac Discovery's Wee-1 kinase inhibitor program. Under the terms of the license…
Read More...

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment, according to a Cancer Research UK…
Read More...

Innocrin Pharmaceuticals announced that it has been granted Small and Medium-Sized Enterprise (SME) status by the European Medicines Agency’s (EMA) Micro, SME office. The SME initiative…
Read More...

Nanotherapeutics announced that Peter H. Khoury, Ph.D., MBA, formerly Senior Vice President and Chief Commercial Officer, has been appointed President and Chief Executive Officer of the…
Read More...

BlackThorn Therapeutics announced that it has received a grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). The…
Read More...

NanoSphere Health Sciences announces that it has signed a Binding Merger Agreement with Corazon Gold Corp. for 100 percent acquisition of NanoSphere’s issued and outstanding shares.…
Read More...

Navidea Biopharmaceuticals announced that it has entered into an exclusive license and distribution agreement  with Sayre Therapeutics for the development and commercialization of Tc…
Read More...

Rigel Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has filed its New Drug Application (NDA) for the use of TAVALISSE™ (fostamatinib disodium) in patients with…
Read More...

Lannett Company announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Amantadine Hydrochloride Capsules…
Read More...

Boehringer Ingelheim announced results from the pivotal Phase III VOLTAIRE-RA study, confirming that its adalimumab biosimilar candidate BI 695501 and HUMIRA have similar efficacy,…
Read More...

Johnson & Johnson announced the completion of the acquisition of Actelion Ltd for a total purchase price of approximately $30 billion in cash. The acquisition was completed through…
Read More...

Baxter International announced an agreement with Dorizoe Lifesciences Limited (Dorizoe), a full-service global contract research and development (R&D) organization, that will…
Read More...

Pfizer and Basilea Pharmaceutica announced that they have entered into an agreement whereby Pfizer will be granted the exclusive commercialization rights in Europe to CRESEMBA…
Read More...